Stock thesis
Arrowhead Pharmaceuticals Inc.
Start with the strongest observed signals, the evidence that could challenge them, and the next source-backed checks.
ARROWHEAD PHARMACEUTICALS INC (ARWR) is a listed warrant, unit, right, or acquisition-company security tracked from 13F filings.
Neutral synthesis
Research orientation
Observed facts, not a rating
Why this name is here
Observed evidence
2 tracked funds report ARWR in their latest available 13F,
representing $125.5M of combined reported value on this page.
- 1 fund reports a new or increased share count in a comparable filing.
- 0 funds report it at 5% or more of the portfolio.
Counter-evidence
What could change the view
1 tracked fund reports a decreased or absent position in the latest comparable filing. Check the size and timing before interpreting the change.
- 13F positions are delayed and exclude short positions and many non-US assets.
- Financial, insider, earnings, or volatility evidence may be missing or point in another direction.
Continue the work
Next research checks
13F holders
Rows are narrowed by movement, fund type, and position size.
2 holders
SEC fundamentals
Financials
Companyfacts
No published earnings analysis yet
We publish a cited report after an eligible official earnings filing is accepted and passes validation.
